Phase II study of biweekly cetuximab+irinotecan therapy for unresectable colorectal cancer
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2626733
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: biweekly cetuximab
Primary outcome(s): Response rate
Study Design: Single arm Non-randomized
创建时间：
2013-06-15
